PDB Short entry for 3II5 HEADER TRANSFERASE 31-JUL-09 3II5 TITLE THE COMPLEX OF WILD-TYPE B-RAF WITH PYRAZOLO PYRIMIDINE TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: B-RAF PROTO-ONCOGENE SERINE/THREONINE-PROTEIN COMPND 3 KINASE; COMPND 4 CHAIN: A, B; COMPND 5 FRAGMENT: UNP RESIDUES 432-726; COMPND 6 SYNONYM: P94, V-RAF MURINE SARCOMA VIRAL ONCOGENE HOMOLOG COMPND 7 B1; COMPND 8 EC: 2.7.11.1; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRAF, BRAF1, RAFB1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS B-RAF, KINASE, PROTEIN-INHIBITOR COMPLEX, ACETYLATION, ATP- KEYWDS 2 BINDING, CARDIOMYOPATHY, CYTOPLASM, DISEASE MUTATION, KEYWDS 3 METAL-BINDING, NUCLEOTIDE-BINDING, PHORBOL-ESTER BINDING, KEYWDS 4 PHOSPHOPROTEIN, POLYMORPHISM, PROTO-ONCOGENE, KEYWDS 5 SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, ZINC, ZINC- KEYWDS 6 FINGER EXPDTA X-RAY DIFFRACTION AUTHOR W.XU,D.BREGER,N.TORRES,M.DUTIA,D.POWELL,G.CISZEWSKI REVDAT 2 17-NOV-09 3II5 1 JRNL REVDAT 1 10-NOV-09 3II5 0 JRNL AUTH D.M.BERGER,N.TORRES,M.DUTIA,D.POWELL,G.CISZEWSKI, JRNL AUTH 2 A.GOPALSAMY,J.I.LEVIN,K.H.KIM,W.XU,J.WILHELM,Y.HU, JRNL AUTH 3 K.COLLINS,L.FELDBERG,S.KIM,E.FROMMER, JRNL AUTH 4 D.WOJCIECHOWICZ,R.MALLON JRNL TITL NON-HINGE-BINDING PYRAZOLO[1,5-A]PYRIMIDINES AS JRNL TITL 2 POTENT B-RAF KINASE INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 19 6519 2009 JRNL REFN ISSN 0960-894X JRNL PMID 19864136 JRNL DOI 10.1016/J.BMCL.2009.10.049 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 2.79 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VICENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE- REMARK 3 : KUNSTLEVE,LI-WEI HUNG,ROBERT IMMORMINO, REMARK 3 : TOM IOERGER,AIRLIE MCCOY,ERIK MCKEE,NIGEL REMARK 3 : MORIARTY,REETAL PAI,RANDY READ,JANE REMARK 3 : RICHARDSON,DAVID RICHARDSON,TOD ROMO,JIM REMARK 3 : SACCHETTINI,NICHOLAS SAUTER,JACOB SMITH, REMARK 3 : LAURENT STORONI,TOM TERWILLIGER,PETER REMARK 3 : ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.79 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.55 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 3 NUMBER OF REFLECTIONS : 21935 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.140 REMARK 3 FREE R VALUE TEST SET COUNT : 1128 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 31.5518 - 5.5804 1.00 2952 145 0.2012 0.2477 REMARK 3 2 5.5804 - 4.4333 1.00 2808 149 0.1697 0.1967 REMARK 3 3 4.4333 - 3.8740 1.00 2773 148 0.1719 0.2184 REMARK 3 4 3.8740 - 3.5203 1.00 2724 152 0.1897 0.2637 REMARK 3 5 3.5203 - 3.2683 0.99 2706 141 0.2174 0.2480 REMARK 3 6 3.2683 - 3.0758 0.96 2597 145 0.2446 0.3058 REMARK 3 7 3.0758 - 2.9218 0.88 2389 139 0.2723 0.3201 REMARK 3 8 2.9218 - 2.7900 0.70 1858 109 0.2979 0.3330 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.33 REMARK 3 B_SOL : 24.54 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.400 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.660 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 4314 REMARK 3 ANGLE : 0.923 5836 REMARK 3 CHIRALITY : 0.060 634 REMARK 3 PLANARITY : 0.003 734 REMARK 3 DIHEDRAL : 16.682 1620 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3II5 COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-AUG-09. REMARK 100 THE RCSB ID CODE IS RCSB054440. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-JUN-06 REMARK 200 TEMPERATURE (KELVIN) : 143 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21935 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.790 REMARK 200 RESOLUTION RANGE LOW (A) : 31.550 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : 0.15200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.79 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 67.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : 0.51500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.350 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS-HCL, PH 8.0, 18% PEG8K, REMARK 280 100MM KH2PO4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.23400 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 55.10950 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 55.10950 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 37.11700 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 55.10950 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 55.10950 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 111.35100 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 55.10950 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.10950 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 37.11700 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 55.10950 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.10950 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 111.35100 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 74.23400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2930 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24160 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 420 REMARK 465 ASP A 421 REMARK 465 ARG A 422 REMARK 465 GLY A 423 REMARK 465 SER A 424 REMARK 465 HIS A 425 REMARK 465 HIS A 426 REMARK 465 HIS A 427 REMARK 465 HIS A 428 REMARK 465 HIS A 429 REMARK 465 HIS A 430 REMARK 465 SER A 431 REMARK 465 GLU A 432 REMARK 465 ASP A 433 REMARK 465 ARG A 434 REMARK 465 ASN A 435 REMARK 465 ARG A 436 REMARK 465 MET A 437 REMARK 465 LYS A 438 REMARK 465 THR A 439 REMARK 465 LEU A 440 REMARK 465 GLY A 441 REMARK 465 ARG A 442 REMARK 465 ARG A 443 REMARK 465 ASP A 444 REMARK 465 SER A 445 REMARK 465 SER A 446 REMARK 465 LYS A 600 REMARK 465 SER A 601 REMARK 465 ARG A 602 REMARK 465 TRP A 603 REMARK 465 SER A 604 REMARK 465 GLY A 605 REMARK 465 SER A 606 REMARK 465 HIS A 607 REMARK 465 GLN A 608 REMARK 465 PHE A 609 REMARK 465 GLU A 610 REMARK 465 LEU A 720 REMARK 465 PRO A 721 REMARK 465 LYS A 722 REMARK 465 ILE A 723 REMARK 465 HIS A 724 REMARK 465 ARG A 725 REMARK 465 MET B 420 REMARK 465 ASP B 421 REMARK 465 ARG B 422 REMARK 465 GLY B 423 REMARK 465 SER B 424 REMARK 465 HIS B 425 REMARK 465 HIS B 426 REMARK 465 HIS B 427 REMARK 465 HIS B 428 REMARK 465 HIS B 429 REMARK 465 HIS B 430 REMARK 465 SER B 431 REMARK 465 GLU B 432 REMARK 465 ASP B 433 REMARK 465 ARG B 434 REMARK 465 ASN B 435 REMARK 465 ARG B 436 REMARK 465 MET B 437 REMARK 465 LYS B 438 REMARK 465 THR B 439 REMARK 465 LEU B 440 REMARK 465 GLY B 441 REMARK 465 ARG B 442 REMARK 465 ARG B 443 REMARK 465 ASP B 444 REMARK 465 SER B 445 REMARK 465 SER B 446 REMARK 465 ASP B 447 REMARK 465 THR B 598 REMARK 465 VAL B 599 REMARK 465 LYS B 600 REMARK 465 SER B 601 REMARK 465 ARG B 602 REMARK 465 TRP B 603 REMARK 465 SER B 604 REMARK 465 GLY B 605 REMARK 465 SER B 606 REMARK 465 HIS B 607 REMARK 465 GLN B 608 REMARK 465 PHE B 609 REMARK 465 GLU B 610 REMARK 465 GLN B 611 REMARK 465 LEU B 612 REMARK 465 SER B 613 REMARK 465 PRO B 721 REMARK 465 LYS B 722 REMARK 465 ILE B 723 REMARK 465 HIS B 724 REMARK 465 ARG B 725 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 521 CG CD CE NZ REMARK 470 GLN A 611 CG CD OE1 NE2 REMARK 470 LEU A 612 CG CD1 CD2 REMARK 470 LYS B 521 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 467 79.91 -115.33 REMARK 500 TRP A 475 97.13 -168.12 REMARK 500 ASN A 485 -44.79 72.56 REMARK 500 PRO A 491 -17.22 -48.14 REMARK 500 LYS A 521 -83.73 -37.60 REMARK 500 GLU A 544 48.80 34.82 REMARK 500 ARG A 574 -6.21 84.38 REMARK 500 ASP A 575 38.08 -153.25 REMARK 500 LYS A 577 160.42 179.59 REMARK 500 LEU A 587 -59.90 -143.87 REMARK 500 ALA A 597 -81.00 -117.08 REMARK 500 LEU A 612 -96.85 60.27 REMARK 500 SER A 613 -83.23 -120.26 REMARK 500 MET A 626 56.11 32.69 REMARK 500 ASP A 628 145.47 84.59 REMARK 500 ASP A 701 0.14 -68.98 REMARK 500 PHE B 467 33.13 -142.64 REMARK 500 GLN B 523 153.95 92.02 REMARK 500 ARG B 574 -1.35 68.53 REMARK 500 ASP B 575 42.56 -163.78 REMARK 500 LEU B 587 -66.35 -126.17 REMARK 500 SER B 615 77.93 -115.75 REMARK 500 ASP B 628 175.33 76.62 REMARK 500 SER B 678 4.03 -65.08 REMARK 500 SER B 719 46.76 -73.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 831 A 1 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 726 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 2 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 831 B 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1UWH RELATED DB: PDB REMARK 900 THE COMPLEX OF WILD TYPE B-RAF AND BAY439006 DBREF 3II5 A 431 725 UNP P15056 BRAF1_HUMAN 432 726 DBREF 3II5 B 431 725 UNP P15056 BRAF1_HUMAN 432 726 SEQADV 3II5 MET A 420 UNP P15056 EXPRESSION TAG SEQADV 3II5 ASP A 421 UNP P15056 EXPRESSION TAG SEQADV 3II5 ARG A 422 UNP P15056 EXPRESSION TAG SEQADV 3II5 GLY A 423 UNP P15056 EXPRESSION TAG SEQADV 3II5 SER A 424 UNP P15056 EXPRESSION TAG SEQADV 3II5 HIS A 425 UNP P15056 EXPRESSION TAG SEQADV 3II5 HIS A 426 UNP P15056 EXPRESSION TAG SEQADV 3II5 HIS A 427 UNP P15056 EXPRESSION TAG SEQADV 3II5 HIS A 428 UNP P15056 EXPRESSION TAG SEQADV 3II5 HIS A 429 UNP P15056 EXPRESSION TAG SEQADV 3II5 HIS A 430 UNP P15056 EXPRESSION TAG SEQADV 3II5 MET B 420 UNP P15056 EXPRESSION TAG SEQADV 3II5 ASP B 421 UNP P15056 EXPRESSION TAG SEQADV 3II5 ARG B 422 UNP P15056 EXPRESSION TAG SEQADV 3II5 GLY B 423 UNP P15056 EXPRESSION TAG SEQADV 3II5 SER B 424 UNP P15056 EXPRESSION TAG SEQADV 3II5 HIS B 425 UNP P15056 EXPRESSION TAG SEQADV 3II5 HIS B 426 UNP P15056 EXPRESSION TAG SEQADV 3II5 HIS B 427 UNP P15056 EXPRESSION TAG SEQADV 3II5 HIS B 428 UNP P15056 EXPRESSION TAG SEQADV 3II5 HIS B 429 UNP P15056 EXPRESSION TAG SEQADV 3II5 HIS B 430 UNP P15056 EXPRESSION TAG SEQRES 1 A 306 MET ASP ARG GLY SER HIS HIS HIS HIS HIS HIS SER GLU SEQRES 2 A 306 ASP ARG ASN ARG MET LYS THR LEU GLY ARG ARG ASP SER SEQRES 3 A 306 SER ASP ASP TRP GLU ILE PRO ASP GLY GLN ILE THR VAL SEQRES 4 A 306 GLY GLN ARG ILE GLY SER GLY SER PHE GLY THR VAL TYR SEQRES 5 A 306 LYS GLY LYS TRP HIS GLY ASP VAL ALA VAL LYS MET LEU SEQRES 6 A 306 ASN VAL THR ALA PRO THR PRO GLN GLN LEU GLN ALA PHE SEQRES 7 A 306 LYS ASN GLU VAL GLY VAL LEU ARG LYS THR ARG HIS VAL SEQRES 8 A 306 ASN ILE LEU LEU PHE MET GLY TYR SER THR LYS PRO GLN SEQRES 9 A 306 LEU ALA ILE VAL THR GLN TRP CYS GLU GLY SER SER LEU SEQRES 10 A 306 TYR HIS HIS LEU HIS ILE ILE GLU THR LYS PHE GLU MET SEQRES 11 A 306 ILE LYS LEU ILE ASP ILE ALA ARG GLN THR ALA GLN GLY SEQRES 12 A 306 MET ASP TYR LEU HIS ALA LYS SER ILE ILE HIS ARG ASP SEQRES 13 A 306 LEU LYS SER ASN ASN ILE PHE LEU HIS GLU ASP LEU THR SEQRES 14 A 306 VAL LYS ILE GLY ASP PHE GLY LEU ALA THR VAL LYS SER SEQRES 15 A 306 ARG TRP SER GLY SER HIS GLN PHE GLU GLN LEU SER GLY SEQRES 16 A 306 SER ILE LEU TRP MET ALA PRO GLU VAL ILE ARG MET GLN SEQRES 17 A 306 ASP LYS ASN PRO TYR SER PHE GLN SER ASP VAL TYR ALA SEQRES 18 A 306 PHE GLY ILE VAL LEU TYR GLU LEU MET THR GLY GLN LEU SEQRES 19 A 306 PRO TYR SER ASN ILE ASN ASN ARG ASP GLN ILE ILE PHE SEQRES 20 A 306 MET VAL GLY ARG GLY TYR LEU SER PRO ASP LEU SER LYS SEQRES 21 A 306 VAL ARG SER ASN CYS PRO LYS ALA MET LYS ARG LEU MET SEQRES 22 A 306 ALA GLU CYS LEU LYS LYS LYS ARG ASP GLU ARG PRO LEU SEQRES 23 A 306 PHE PRO GLN ILE LEU ALA SER ILE GLU LEU LEU ALA ARG SEQRES 24 A 306 SER LEU PRO LYS ILE HIS ARG SEQRES 1 B 306 MET ASP ARG GLY SER HIS HIS HIS HIS HIS HIS SER GLU SEQRES 2 B 306 ASP ARG ASN ARG MET LYS THR LEU GLY ARG ARG ASP SER SEQRES 3 B 306 SER ASP ASP TRP GLU ILE PRO ASP GLY GLN ILE THR VAL SEQRES 4 B 306 GLY GLN ARG ILE GLY SER GLY SER PHE GLY THR VAL TYR SEQRES 5 B 306 LYS GLY LYS TRP HIS GLY ASP VAL ALA VAL LYS MET LEU SEQRES 6 B 306 ASN VAL THR ALA PRO THR PRO GLN GLN LEU GLN ALA PHE SEQRES 7 B 306 LYS ASN GLU VAL GLY VAL LEU ARG LYS THR ARG HIS VAL SEQRES 8 B 306 ASN ILE LEU LEU PHE MET GLY TYR SER THR LYS PRO GLN SEQRES 9 B 306 LEU ALA ILE VAL THR GLN TRP CYS GLU GLY SER SER LEU SEQRES 10 B 306 TYR HIS HIS LEU HIS ILE ILE GLU THR LYS PHE GLU MET SEQRES 11 B 306 ILE LYS LEU ILE ASP ILE ALA ARG GLN THR ALA GLN GLY SEQRES 12 B 306 MET ASP TYR LEU HIS ALA LYS SER ILE ILE HIS ARG ASP SEQRES 13 B 306 LEU LYS SER ASN ASN ILE PHE LEU HIS GLU ASP LEU THR SEQRES 14 B 306 VAL LYS ILE GLY ASP PHE GLY LEU ALA THR VAL LYS SER SEQRES 15 B 306 ARG TRP SER GLY SER HIS GLN PHE GLU GLN LEU SER GLY SEQRES 16 B 306 SER ILE LEU TRP MET ALA PRO GLU VAL ILE ARG MET GLN SEQRES 17 B 306 ASP LYS ASN PRO TYR SER PHE GLN SER ASP VAL TYR ALA SEQRES 18 B 306 PHE GLY ILE VAL LEU TYR GLU LEU MET THR GLY GLN LEU SEQRES 19 B 306 PRO TYR SER ASN ILE ASN ASN ARG ASP GLN ILE ILE PHE SEQRES 20 B 306 MET VAL GLY ARG GLY TYR LEU SER PRO ASP LEU SER LYS SEQRES 21 B 306 VAL ARG SER ASN CYS PRO LYS ALA MET LYS ARG LEU MET SEQRES 22 B 306 ALA GLU CYS LEU LYS LYS LYS ARG ASP GLU ARG PRO LEU SEQRES 23 B 306 PHE PRO GLN ILE LEU ALA SER ILE GLU LEU LEU ALA ARG SEQRES 24 B 306 SER LEU PRO LYS ILE HIS ARG HET 831 A 1 38 HET PO4 A 726 5 HET PO4 A 2 5 HET 831 B 1 38 HETNAM 831 N-[3-(3-{4-[(DIMETHYLAMINO)METHYL]PHENYL}PYRAZOLO[1,5- HETNAM 2 831 A]PYRIMIDIN-7-YL)PHENYL]-3-(TRIFLUOROMETHYL)BENZAMIDE HETNAM PO4 PHOSPHATE ION FORMUL 3 831 2(C29 H24 F3 N5 O) FORMUL 4 PO4 2(O4 P 3-) FORMUL 7 HOH *21(H2 O) HELIX 1 1 THR A 490 ARG A 505 1 16 HELIX 2 2 LEU A 536 ILE A 542 1 7 HELIX 3 3 GLU A 548 LYS A 569 1 22 HELIX 4 4 LYS A 577 ASN A 579 5 3 HELIX 5 5 SER A 615 MET A 619 5 5 HELIX 6 6 ALA A 620 ARG A 625 1 6 HELIX 7 7 SER A 633 GLY A 651 1 19 HELIX 8 8 ASN A 660 ARG A 670 1 11 HELIX 9 9 ASP A 676 VAL A 680 5 5 HELIX 10 10 PRO A 685 LEU A 696 1 12 HELIX 11 11 LYS A 699 ARG A 703 5 5 HELIX 12 12 LEU A 705 ARG A 718 1 14 HELIX 13 13 GLN B 492 ARG B 505 1 14 HELIX 14 14 SER B 535 ILE B 542 1 8 HELIX 15 15 GLU B 548 LYS B 569 1 22 HELIX 16 16 LYS B 577 ASN B 579 5 3 HELIX 17 17 GLU B 585 LEU B 587 5 3 HELIX 18 18 SER B 615 MET B 619 5 5 HELIX 19 19 ALA B 620 MET B 626 1 7 HELIX 20 20 SER B 633 GLY B 651 1 19 HELIX 21 21 ASN B 660 ARG B 670 1 11 HELIX 22 22 ASP B 676 VAL B 680 5 5 HELIX 23 23 PRO B 685 LEU B 696 1 12 HELIX 24 24 LYS B 699 ARG B 703 5 5 HELIX 25 25 LEU B 705 SER B 719 1 15 SHEET 1 A 5 THR A 457 GLY A 465 0 SHEET 2 A 5 GLY A 468 LYS A 474 -1 O VAL A 470 N ILE A 462 SHEET 3 A 5 ASP A 478 MET A 483 -1 O MET A 483 N THR A 469 SHEET 4 A 5 ALA A 525 GLN A 529 -1 O THR A 528 N ALA A 480 SHEET 5 A 5 PHE A 515 SER A 519 -1 N GLY A 517 O VAL A 527 SHEET 1 B 3 GLY A 533 SER A 535 0 SHEET 2 B 3 ILE A 581 HIS A 584 -1 O LEU A 583 N SER A 534 SHEET 3 B 3 THR A 588 ILE A 591 -1 O LYS A 590 N PHE A 582 SHEET 1 C 5 THR B 457 GLY B 465 0 SHEET 2 C 5 GLY B 468 LYS B 474 -1 O VAL B 470 N ILE B 462 SHEET 3 C 5 ASP B 478 MET B 483 -1 O MET B 483 N THR B 469 SHEET 4 C 5 ALA B 525 GLN B 529 -1 O ILE B 526 N LYS B 482 SHEET 5 C 5 PHE B 515 SER B 519 -1 N GLY B 517 O VAL B 527 SHEET 1 D 2 ILE B 581 HIS B 584 0 SHEET 2 D 2 THR B 588 ILE B 591 -1 O LYS B 590 N PHE B 582 CISPEP 1 LYS B 521 PRO B 522 0 -5.73 SITE 1 AC1 11 HOH A 16 ILE A 462 LYS A 482 GLU A 500 SITE 2 AC1 11 LEU A 513 THR A 528 HIS A 573 GLY A 592 SITE 3 AC1 11 ASP A 593 PHE A 594 ARG B 670 SITE 1 AC2 6 HOH A 6 ASP A 447 TRP A 449 ARG A 505 SITE 2 AC2 6 TRP B 449 ARG B 505 SITE 1 AC3 4 GLN A 529 THR A 588 LYS A 590 LYS B 590 SITE 1 AC4 9 LYS B 482 GLU B 500 LEU B 504 ILE B 526 SITE 2 AC4 9 THR B 528 ILE B 591 GLY B 592 ASP B 593 SITE 3 AC4 9 PHE B 594 CRYST1 110.219 110.219 148.468 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009073 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009073 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006735 0.00000